Concepedia

Damon Bass

DB

20

Publications

1.6K

Citations

16

H-Index

2013

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

Age UK

Research Triangle Park Foundation

University of Southern California

Damon Bass is an author at GlaxoSmithKline (United States) specializing in autoimmunity, rheumatology, and autoimmune disease.

ORCID

Top concepts

Publications per year

2013–2022

20

Publications

20

Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled Study

William Stohl, Andreas Schwarting, Masato Okada et al. · Arthritis & Rheumatology · 2017 · 391 citations · Full text

A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea

Fengchun Zhang, Sang‐Cheol Bae, Damon Bass et al. · Annals of the Rheumatic Diseases · 2018 · 277 citations · Full text

A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis

Brad H. Rovin, Richard Furie, Y K Onno Teng et al. · Kidney International · 2021 · 184 citations · Full text

Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial

Hermine I. Brunner, Carlos Abud‐Mendoza, Diego Oscar Viola et al. · Annals of the Rheumatic Diseases · 2020 · 179 citations · Full text

Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan

Cindy Garris, Priti Jhingran, Damon Bass et al. · Journal of Medical Economics · 2013 · 117 citations · Full text

Rows per page

1–5 of 20